Kelly-Ann Sheppard
- Molecular Biology top 5%
- Oncology top 2%
- Immunology top 2%
- Cancer Research top 5%
- Genetics top 10%
- Co-authors
- Charles N. SerhanAmy S. YeeChristopher K. GlassMichael G. RosenfeldTucker CollinsDimitris ThanosMin XuCheng‐Yuan Peng
- Topics
- Cancer-related Molecular Pathways (5 papers)TGF-β signaling in diseases (3 papers)Ubiquitin and proteasome pathways (3 papers)
- Cited by
- ImmunologyOncologyCancer Research
- Partner nations
- United StatesNetherlandsChina
In The Last Decade
Kelly-Ann Sheppard
17 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Molecular Biology 1.7k
- Oncology 1.2k
- Immunology 958
- Cancer Research 514
- Genetics 338
Countries citing papers authored by Kelly-Ann Sheppard
This map shows the geographic impact of Kelly-Ann Sheppard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly-Ann Sheppard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly-Ann Sheppard more than expected).
Fields of papers citing papers by Kelly-Ann Sheppard
This network shows the impact of papers produced by Kelly-Ann Sheppard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly-Ann Sheppard. The network helps show where Kelly-Ann Sheppard may publish in the future.
Co-authorship network of co-authors of Kelly-Ann Sheppard
This figure shows the co-authorship network connecting the top 25 collaborators of Kelly-Ann Sheppard. A scholar is included among the top collaborators of Kelly-Ann Sheppard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly-Ann Sheppard. Kelly-Ann Sheppard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 160 | |
| 2 | 56 | |
| 3 | 196 | |
| 4 | 232 | |
| 5 | 4 | |
| 6 | 257 | |
| 7 | 78 | |
| 8 | PD‐1 inhibits T‐cell receptor induced phosphorylation of the ZAP70/CD3ζ signalosome and downstream signaling to PKCθbreakdown → | 631 |
| 9 | 379 | |
| 10 | 243 | |
| 11 | 128 | |
| 12 | 80 | |
| 13 | 250 | |
| 14 | 34 | |
| 15 | 39 | |
| 16 | 10 | |
| 17 | 247 |
About Kelly-Ann Sheppard
Kelly-Ann Sheppard is a scholar working on Cancer Research, Oncology and Ophthalmology, having authored 17 papers that have together received 3.0k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (5 papers), TGF-β signaling in diseases (3 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Immunology (958 citations), Oncology (1.2k citations) and Cancer Research (514 citations). Kelly-Ann Sheppard has collaborated with scholars based in United States, Netherlands and China. Frequent co-authors include Charles N. Serhan, Amy S. Yee, Christopher K. Glass, Michael G. Rosenfeld, Tucker Collins, Dimitris Thanos, Min Xu, Cheng‐Yuan Peng, Helen Piwnica‐Worms and Lori Fitz. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.